5 Trends Impacting Pharmaceutical Contract Lifecycle Management
Dealing with challenging trends such as rising costs, evolving supply chain dynamics, the need for faster innovation, slowing growth, and policy and regulatory changes are an ongoing reality and have a direct impact on a pharma or biotech organization’s contracts. Whether it’s buy-side agreements with suppliers, sell-side negotiations with Pharmacy Benefit Managers (PBMs), or even managing clinical trials with Contract Research Organizations (CROs), contract management plays a vital role. This article looks at each one of these trends as they relate to pharmaceutical contract lifecycle management.
